Sarah E. Taylor

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

19h-index3.2kcitations148works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Growth Hormone and Insulin-like Growth Factors(20), Single-cell and spatial transcriptomics(16), Cancer, Hypoxia, and Metabolism(10), Cancer Genomics and Diagnostics(10), RNA modifications and cancer(10)

Publications147 total

Biomarker Quantification in Breast Cancer using Xenium In Situ
2025Open Access
Supp Figure 6 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 4 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Data from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
B56-alpha OE Vector Map from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 7 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 8 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Raw PCA Data from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 2 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
EGFP OE Vector Map from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 11 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
IDEXX Cell Line Verification from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 3 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supplementary Figure Legends from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 9 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 12 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 1 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
TCGA Patient IDs from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Key Resources Table from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
Supp Figure 10 from Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
2025Open Access
page 1 of 8Next →

Frequent Co-authors

Goutham Narla(5), Mark W. Jackson(5), Stephen R. Williams(4), Caitlin M. O’Connor(4), Amanda Janesick(3), Michelli F. Oliveira(3), Jaya Sangodkar(3), Douglas M. Whiteside(3), Michael R. Basso(3), Savana M. Naini(3), Erin Holker(3), Eric J. Waldron(3), James Bagnall(3), Analisa DiFeo(3), Benjamin L. Bryson(3), David G. Fernig(3), David M. Feldser(2), Monte M. Winslow(2), Tyler Jacks(2), Lynette Bower(2)